Targeted Tx for AdvSM
Expert Insights on Targeted Therapies for Advanced Systemic Mastocytosis

Released: March 10, 2022

Expiration: March 09, 2023

Prithviraj Bose
Prithviraj Bose, MD
Ilene A. Galinsky
Ilene A. Galinsky, NP
Caitlin R Rausch
Caitlin R Rausch, PharmD, BCOP

Activity

Progress
1
Course Completed

In this episode, Dr Prithviraj Bose, Pharmacist Caitlin R. Rausch, and Nurse Practitioner Ilene A. Galinsky discuss incorporating KIT-targeted therapies into management of patients with advanced systemic mastocytosis. Topics include:

  • Diagnosis and prognosis of advanced systemic mastocytosis
  • Clinical trial data on efficacy of avapritinib and midostaurin
  • Monitoring for and managing key toxicities with avapritinib, including cognitive dysfunction